Treatment Length: Ongoing treatment typically lasts 812 weeks , with regular progress check-ins
Confin Neurol
Sheridan, School of Medicine, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland This article was submitted to Fungi and Their Interactions, a section of the journal Frontiers in Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The benefit of GLP-1 RAs appears to be time-dependent: in the LEADER trial, for instance, the absolute risk reduction in all-cause death became more pronounced with longer follow-up, rising from 0.3% at 1 year to 1.4% at 3 years [40]
Lee MMY, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter NR, Badve SV, Pratley RE, Perkovic V, Buse JB, McGuire DK
Some evidence suggests potential effects on non-alcoholic fatty liver disease, though these benefits vary by specific medication and patient population
.webp)
